Havens Advisors’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Havens Advisors’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-46,000	Closed	-$3.13M	–	51
2022 Q3	$3.13M	Buy	+46,000	New	+$2.54M	4.69%	6

Other funds holding GBT

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Havens Advisors's GBT Position: Q4 2022 in Review

Havens Advisors sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 46,000 shares — an estimated $3.13M sold.

Havens Advisors first reported a position in GBT in Q3 2022 and held it in 1 quarter. The position peaked at $3.13M in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

Havens Advisors reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
Havens Advisors sold 46,000 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $3.13M.
Havens Advisors first reported a position in Global Blood Therapeutics, Inc. in Q3 2022 and held it in 1 quarter.
Havens Advisors's Global Blood Therapeutics, Inc. position peaked at $3.13M in Q3 2022.
2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Havens Advisors's 13F filing for Q4 2022, filed 25 Jan 2023.